Skip to main content

Videos

Headshot of Lynn Carroll, HSBlox, on a blue background underneath the PopHealth Perspectives logo.
Videos
01/31/2022
Lynn Carroll, chief operating officer and head of strategy, HSBlox, offers insight into the current shift toward value-based care payment models, challenges regarding data use, and how contracts may be structured in the future.
Lynn Carroll, chief operating officer and head of strategy, HSBlox, offers insight into the current shift toward value-based care payment models, challenges regarding data use, and how contracts may be structured in the future.
Lynn Carroll, chief operating...
01/31/2022
First Report Managed Care
Ajeet Gajra, MD, FACS
Videos
01/21/2022
Ajeet Gajra, MD, FACS, discusses survey results analyzing community oncologists/hematologists’ perceptions of gene therapies and barriers to adoption or integration into clinical practice.
Ajeet Gajra, MD, FACS, discusses survey results analyzing community oncologists/hematologists’ perceptions of gene therapies and barriers to adoption or integration into clinical practice.
Ajeet Gajra, MD, FACS, discusses...
01/21/2022
Journal of Clinical Pathways
Dr
Videos
01/19/2022
Dr Rosmarin shares his thoughts on the impact of vitiligo on patient quality of life, including what we need to understand as novel therapies emerge.
Dr Rosmarin shares his thoughts on the impact of vitiligo on patient quality of life, including what we need to understand as novel therapies emerge.
Dr Rosmarin shares his thoughts...
01/19/2022
The Dermatologist
Headshot of Matthew Albright, Zelis, on a blue background underneath the PopHealth Perspectives logo.
Videos
01/18/2022
Matthew Albright, chief legislative affairs officer, Zelis, discusses a Zelis survey highlighting payers’ concerns about No Surprises Act requirements, and offers advice for payers seeking to achieve compliance.
Matthew Albright, chief legislative affairs officer, Zelis, discusses a Zelis survey highlighting payers’ concerns about No Surprises Act requirements, and offers advice for payers seeking to achieve compliance.
Matthew Albright, chief...
01/18/2022
First Report Managed Care
Sonja Ständer, MD, specializes in novel therapies for chronic pruritus and chronic prurigo including prurigo nodularis.
Videos
10/19/2021
Following her presentation at Dermatology Week, Dr Sonja Stander presented her insights into the prurigo nodularis guidelines in this video.
Following her presentation at Dermatology Week, Dr Sonja Stander presented her insights into the prurigo nodularis guidelines in this video.
Following her presentation at...
10/19/2021
The Dermatologist
Headshot of Scott Collins, Chris Hobson, Jim Sdoia, Matthew Michela on a blue background underneath the PopHealth Perspectives logo.
Roundtable
10/05/2021
In this roundtable, Scott Collins, president of marketing at ARIA, moderates a conversation with Matthew A Michela, MBA, president and chief executive officer of Life Image; Chris Hobson, MD, MBA, chief medical officer of Orion Health; and...
In this roundtable, Scott Collins, president of marketing at ARIA, moderates a conversation with Matthew A Michela, MBA, president and chief executive officer of Life Image; Chris Hobson, MD, MBA, chief medical officer of Orion Health; and...
In this roundtable, Scott...
10/05/2021
Integrated Healthcare Executive
Dr Shen
Videos
09/21/2021
John Shen, MD, UCLA, discusses a combined analysis of TITAN & SPARTAN, apalutamide (APA) therapy for older patients with advanced prostate cancer, presented at the 2021 ESMO Congress.
John Shen, MD, UCLA, discusses a combined analysis of TITAN & SPARTAN, apalutamide (APA) therapy for older patients with advanced prostate cancer, presented at the 2021 ESMO Congress.
John Shen, MD, UCLA, discusses a...
09/21/2021
Oncology
Headshot of Shephard Mpofu on a blue background underneath the PopHealth Perspectives logo.
Videos
08/16/2021
Shephard Mpofu, MD, senior vice president and chief medical officer, Novartis Gene Therapies, discusses findings from SPR1NT, a phase 3 clinical trial in which Zolgensma (onasemnogene abeparvovec-xioi) was effective in treating patients with...
Shephard Mpofu, MD, senior vice president and chief medical officer, Novartis Gene Therapies, discusses findings from SPR1NT, a phase 3 clinical trial in which Zolgensma (onasemnogene abeparvovec-xioi) was effective in treating patients with...
Shephard Mpofu, MD, senior vice...
08/16/2021
First Report Managed Care
Headshot of Jeffrey Stark on a blue background underneath the PopHealth Perspectives logo.
Videos
07/26/2021
Jeffrey Stark, MD, head of immunology medical affairs, UCB, breaks down the unique challenges patients with psoriasis face, and discusses the BE RADIANT and BE SURE studies, both of which indicated that bimekizumab was effective at achieving...
Jeffrey Stark, MD, head of immunology medical affairs, UCB, breaks down the unique challenges patients with psoriasis face, and discusses the BE RADIANT and BE SURE studies, both of which indicated that bimekizumab was effective at achieving...
Jeffrey Stark, MD, head of...
07/26/2021
First Report Managed Care
Videos
06/18/2021
In this video, Carlos H. Schenck, MD, Professor of Psychiatry, University of Minnesota Medical School; Senior Staff Physician, Minnesota Regional Sleep Disorders Center, Hennepin County Medical Center, Minneapolis, Minnesota, discusses his...
In this video, Carlos H. Schenck, MD, Professor of Psychiatry, University of Minnesota Medical School; Senior Staff Physician, Minnesota Regional Sleep Disorders Center, Hennepin County Medical Center, Minneapolis, Minnesota, discusses his...
In this video, Carlos H....
06/18/2021
Neurology